Nucleate Podcast cover image

Building Biotech: From the Lab to the Boardroom | Raj Devraj, CEO of Rectify Pharma

Nucleate Podcast

00:00

Expanding Horizons in Biotech

This chapter explores the innovative transition of a platform initially focused on rare monogenic diseases to address a wider array of common conditions. It highlights the importance of experimental courage and the integration of insights from structural biology to enhance the application of small molecules in correcting protein mutations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app